Andrx to Present at Lehman Brothers Annual Global Healthcare Conferenc

Andrx to Present at Lehman Brothers Annual Global Healthcare Conference

    Business Editors/Health/Medical Writers
    Lehman Brothers Eighth Annual Global Healthcare Conference

    FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--March 25, 2005--Andrx Corporation (Nasdaq:ADRX) is scheduled to present on Wednesday, March 30, 2005, at 10:45 AM ET at the Lehman Brothers Eighth Annual Global Healthcare Conference at The Loews Miami Beach Hotel in Miami, Florida. Angelo C. Malahias, Andrx Corporation's President, will present on behalf of the Company and, accompanied by Larry Rosenthal, President of Andrx Pharmaceuticals, Inc., Andrx's generic business, will address questions from the audience.
    The presentation will be webcast live on the Internet at the following web address: http://customer.talkpoint.com/LEHM002/033005a_cs/default.asp?entity= Andrx (Due to its length, this URL may need to be copied/pasted into your Internet browser's address field. Remove the extra space if one exists.)
    A replay of the presentation will be available within 24 hours of the broadcast and will be available until April 30, 2005. It may be accessed through the same web address. A link to the broadcast, along with the slides for this presentation, will be available on Andrx's website at: http://www.andrx.com.

    About Andrx Corporation:

    We are a pharmaceutical company that:

--	develops, manufactures and commercializes generic versions of controlled-release, niche and immediate-release pharmaceutical products, including oral contraceptives; and
--	distributes pharmaceuticals, primarily generics, which have been commercialized by others, as well as our own, primarily to independent pharmacies, pharmacy chains, pharmacy buying groups and physicians' offices.

    We also commercialize brand pharmaceuticals that, in some instances, use our proprietary controlled-release drug delivery technologies. On March 2, 2005, we entered into agreements with First Horizon Pharmaceutical Corporation for the sale and licensing of certain rights and assets related to our two main brand products, Altoprev and Fortamet. The closing of the transaction is subject to certain customary conditions.
    This release and additional information about Andrx Corporation are also available on the Internet at: http://www.andrx.com.

    Forward-looking statements (statements which are not historical facts) in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We are subject to risks and uncertainties detailed from time to time in our filings with the Securities and Exchange Commission. We disclaim any intent or obligation to update the forward-looking statements except as expressly required by law.

--30--PP/mi*

CONTACT: Andrx Corporation, Fort Lauderdale Allison Tomek, 954-382-7696 Email: allison.tomek@andrx.com

KEYWORD: FLORIDA TRACK INDUSTRY KEYWORD: PHARMACEUTICAL MEDICAL TRADESHOW SOURCE: Andrx Corporation

Copyright Business Wire 2005